Evaluation of neutralizing antibody titers against SARS-CoV-2 JN.1 omicron subvariant during pregnancy - A case series study
Open Access
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Vaccination from the early second trimester onwards gives a robust SARS-CoV-2 antibody response throughout pregnancy and provides antibodies for the neonateInternational Journal of Infectious Diseases, 2023
- Transplacental transfer of SARS-CoV-2 antibodies: a cohort studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2023
- Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 boosterJournal of Medical Virology, 2022
- Association of COVID-19 Vaccination During Early Pregnancy With Risk of Congenital Fetal AnomaliesJAMA Pediatrics, 2022
- Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy OutcomesJAMA, 2022
- Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum OutcomesJAMA, 2022
- Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort studyClinical Microbiology and Infection, 2021
- Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort studyAmerican Journal of Obstetrics and Gynecology, 2021
- Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating WomenJAMA, 2021
- Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 PandemicJAMA Network Open, 2020